Latest Breaking News On - Hansa executive committee - Page 1 : comparemela.com

Hansa Biopharma AB: Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer

Hansa Biopharma AB: Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaUnited statesEvan ballantyneKlaus sindahlHansa biopharmaPrnewswire hansa biopharmaDonato spotaStephanie kenneyUniversity of western ontarioGain therapeutics incVp global corporate affairsHonors business administrationUniversity of windsorHansa executive committeePreveceutical medical inc

Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer

/PRNewswire/ Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), today announced the appointment of Evan Ballantyne as Chief Financial Officer (CFO),.

United statesUnited kingdomBritish columbiaPrnewswire hansa biopharmaStephanie kenneyDonato spotaEvan ballantyneKlaus sindahlHansa biopharmaHansa executive committeePreveceutical medical incHonors business administrationUniversity of windsorGain therapeutics incVp global corporate affairsUniversity of western ontario

Hansa Biopharma AB: Dr Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

Hansa Biopharma AB: Dr Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Sanofi biologicsStephanie kenneyKlaus sindahlHitto kaufmannPrnewswire hansa biopharmaHansa biopharmaSwiss federal institute of technologyTechnical university of braunschweigHansa executive committeePieris pharmaceuticalsVp global corporate affairsResearch scientistGlobal biopharmaceutics developmentEliza hall instituteScripps research instituteBoehringer ingelheim

Dr Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

/PRNewswire/ Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr..

Hansa biopharmaHitto kaufmannSanofi biologicsPrnewswire hansa biopharmaKlaus sindahlStephanie kenneyScripps research instituteEliza hall instituteBoehringer ingelheimResearch scientistIndustrial affairsHansa executive committeeSwiss federal institute of technologyTechnical university of braunschweigGlobal biopharmaceutics developmentVp global corporate affairs